Driving the commercialisation of industrial biomanufacturing in Europe
1-2-1 MEETINGS | CONFERENCE | NETWORKING
Headline Partners
The only event dedicated to scaling industrial biomanufacturing in Europe
Bio Innovations Europe (previously known as World Bio Markets) connects over 500 bio-pioneers through a programme of pre-arranged 1-2-1 meetings, knowledge exchange, and networking.
The two-day business development event facilitates commercial connections and generates deal flow between bio-developers & producers, chemical manufacturers, consumer brands & intermediates, community enablers, investors & financiers and suppliers.
The unique 1-2-1 meetings format makes it easy for companies to meet new customers and partners, grow business development pipelines, source new innovations, secure investment and scale at a faster rate.
ATTENDEES
0
1-2-1 MEETINGS
0
SPEAKERS
0
The event where science meets business
One thing is clear – the sector is at a tipping point. We already have enough great, innovative ideas. But the time has come to focus on enabling those existing solutions to commercialise and reach industrial scale. That’s what we’re here for.
Scientists talking to scientists has value but not as much as scientists meeting the partners and customers that can take their innovation from lab to market.
It’s not just networking, it’s deal making.
Meet our sponsors and partners
Focused on commercial 1-2-1 meetings
Unlike typical conferences, Bio Innovations Europe is built around high-value, pre-arranged 1-2-1 meetings – designed to spark strategic partnerships and drive commercial deals.
We are globally recognised as the event where meetings are made, and business gets done. Last year, we facilitated over 1,050 meetings – that’s a 550% increase since our launch in 2022.
Why Europe and why now?
2026 will be a pivotal year for Europe’s industrial biomanufacturing industry with major new EU policy initiatives set to catalyse and accelerate scale-up of the sector.
Under its net zero commitments, EU petrochemical emissions must drop 90% by 2040 with bio-based alternatives as a key enabler. This transition requires an estimated 20x scale-up of Europe’s industrial biomanufacturing capacity – A huge opportunity!
The EU’s newly announced Bioeconomy Strategy, alongside upcoming legislation including the EU Biotech Act and Circular Economy Act, will streamline approvals of new bio-based products, substantially increase public and private funding for scale-ups, increase availability of bio-waste feedstocks, and stimulate market demand with an alliance of major companies across Europe committed to purchasing €10B bio-based solutions by 2030.
At such an exciting time for the industry, now is the time to connect and build partnerships with those at the heart of Europe’s industrial biomanufacturing scale-up.
Who needs to attend
- Companies creating chemicals, ingredients and materials from bio-based feedstocks and looking to meet the partners that will help them scale their business, increase production volumes and move from lab to market
- Chemical manufacturers scouting for new bio-based innovations to partner with or bring in house to help further future proof their manufacturing agenda
- Consumer brands searching for bio-based chemicals, ingredients and materials that can support their defossilization strategy
- Enablers who have the expertise, infrastructure and intelligence to help developers avoid the valley of death and reduce the time taken to complete the journey from lab to market
- Established investors looking for new innovations and syndicate opportunities, and those trying to better understand how bio can help future-proof their portfolios
- Providers of the solutions that can improve efficiency, performance and results and who are looking to position themselves as the scaleup partner of choice
These companies attended in 2025:
The leading global event series
Our business development events are the world leaders in creating the connections and partnerships needed to advance industrial biomanufacturing.
For us, success means making bio the new normal
Our mission is to contribute to the global adoption of industrial biomanufacturing, and enable bio-based solutions to achieve price parity with fossil-derived incumbents.
Our focus is on connecting commercialised bio producers with customers, and improving the success rates of startups and scaleups.
We’ll achieve our mission through continuing to embed ourselves within the sector, arrange targeted commercial meetings and curate world-class discussion and debate.